David Parry is currently the Franchise Head of Pricing and Market Access and Health Economics for DNA Damage Repair, Tumour Drivers, and Resistance at AstraZeneca Global in Cambridge, UK. Since 2019, David has led a team of approximately 20 experts in ensuring that clinical trial programs deliver reimbursable medicines and supporting country marketing teams in price negotiations. Prior to this role, David held various positions at AstraZeneca, including Global Price and Reimbursement Director for Lynparza, and worked at Bristol-Myers Squibb as Associate Director, leading UK Global Epidemiology and Outcomes Research. David began their career at Pfizer as a Senior Manager in Health Economics and Outcomes Research and was a Lecturer at the University of Birmingham from 1997 to 2000.
This person is not in any teams
This person is not in any offices